Largest Biotech companies by Market Cap
| Rank | Name | Market Cap | Price | Today | Price (30 days) | Country | |
|---|---|---|---|---|---|---|---|
 | 1 |  Eli Lilly LLY | $724.99 B | $807.58 | 1.44% |  USA | |
| 2 |  Johnson & Johnson JNJ | $373.47 B | $155.22 | 1.20% | USA | |
| 3 |  Novo Nordisk NVO | $342.74 B | $77.02 | 3.52% |  Denmark | |
| 4 |  AbbVie ABBV | $337.13 B | $190.86 | 0.12% | USA | |
| 5 |  Roche ROG.SW | $259.11 B | $322.91 | 0.08% |  Switzerland | |
| 6 |  Novartis NVS | $234.35 B | $118.09 | 1.14% | Switzerland | |
| 7 |  AstraZeneca AZN | $232.04 B | $73.55 | 1.17% |  UK | |
| 8 |  Merck MRK | $203.29 B | $80.96 | 0.07% | USA | |
| 9 |  Amgen AMGN | $158.92 B | $295.56 | 0.12% | USA | |
| 10 |  Thermo Fisher Scientific TMO | $152.91 B | $405.08 | 0.58% | USA | |
| 11 |  Pfizer PFE | $138.72 B | $24.40 | 0.57% | USA | |
| 12 |  Gilead Sciences GILD | $137.86 B | $110.83 | 0.77% | USA | |
| 13 |  Sanofi SNY | $122.58 B | $49.41 | 0.52% |  France | |
| 14 |  Vertex Pharmaceuticals VRTX | $115.79 B | $450.91 | 1.00% | USA | |
| 15 |  Bristol-Myers Squibb BMY | $99.02 B | $48.66 | 2.19% | USA | |
| 116 |  Chugai Pharmaceutical 4519.T | $83.94 B | $51.01 | 1.05% |  Japan | |
| 117 |  GlaxoSmithKline GSK | $83.42 B | $40.49 | 0.91% | UK | |
| 18 |  CSL CSL.AX | $75.66 B | $156.27 | 0.08% |  Australia | |
| 19 |  Zoetis ZTS | $73.18 B | $164.38 | 0.03% | USA | |
| 20 |  Regeneron Pharmaceuticals REGN | $56.43 B | $522.68 | 1.24% | USA | |
| 21 |  Samsung Biologics 207940.KS | $52.72 B | $740.81 | 0.49% |  S. Korea | |
| 22 |  Lonza LONN.SW | $49.99 B | $693.03 | 0.56% | Switzerland | |
| 23 |  Jiangsu Hengrui Medicine 600276.SS | $47.69 B | $7.22 | 3.57% |  China | |
| 24 |  Takeda Pharmaceutical TAK | $47.07 B | $15.07 | 0.86% | Japan | |
| 25 |  Sun Pharmaceutical SUNPHARMA.NS | $46.04 B | $19.19 | 1.96% |  India | |
| 26 |  Daiichi Sankyō 4568.T | $44.41 B | $23.85 | 1.23% | Japan | |
| 27 |  Alnylam Pharmaceuticals ALNY | $40.26 B | $308.78 | 0.26% | USA | |
| 28 |  UCB UCB.VI | $35.71 B | $186.89 | 0.52% |  Belgium | |
| 29 |  Argenx ARGX | $35.59 B | $551.22 | 4.62% |  Netherlands | |
| 30 |  Novozymes NZYM.VI | $34.88 B | $74.83 | 0.74% | Denmark | |
| 31 |  Agilent Technologies A | $33.80 B | $119.02 | 1.66% | USA | |
| 132 |  DexCom DXCM | $32.54 B | $83.00 | 1.23% | USA | |
| 133 |  Galderma Group GALD.SW | $31.98 B | $134.72 | 0.63% | Switzerland | |
| 134 |  Bayer BAYN.DE | $30.67 B | $31.22 | 2.03% |  Germany | |
| 135 |  BeOne Medicines ONC | $30.55 B | $264.42 | 1.93% | China | |
| 136 |  Celltrion 068270.KS | $26.86 B | $118.68 | 0.00% | S. Korea | |
| 137 |  WuXi AppTec 2359.HK | $26.74 B | $9.75 | 3.65% | China | |
| 38 |  Otsuka Holdings 4578.T | $26.23 B | $49.68 | 0.31% | Japan | |
| 39 |  BioNTech BNTX | $25.56 B | $106.33 | 0.23% | Germany | |
| 40 |  Sandoz Group SDZ.SW | $22.40 B | $52.02 | 0.42% | Switzerland | |
| 141 |  LabCorp LH | $22.09 B | $263.96 | 1.09% | USA | |
| 142 |  Hansoh Pharma 3692.HK | $21.43 B | $3.61 | 3.41% | China | |
| 43 |  Divis Laboratories DIVISLAB.NS | $20.16 B | $75.96 | 2.20% | India | |
| 44 |  Teva Pharmaceutical Industries TEVA | $20.06 B | $17.50 | 3.00% |  Israel | |
| 45 |  Royalty Pharma RPRX | $19.73 B | $35.10 | 0.75% | UK | |
| 146 |  Insmed INSM | $19.29 B | $101.59 | 2.90% | USA | |
| 147 |  Biogen BIIB | $19.20 B | $131.04 | 0.30% | USA | |
| 48 |  Astellas Pharma 4503.T | $17.10 B | $9.55 | 0.18% | Japan | |
| 149 |  bioMérieux BIM.PA | $16.48 B | $137.89 | 1.24% | France | |
| 150 |  Innovent Biologics 1801.HK | $16.09 B | $9.82 | 3.99% | China | |
| 51 |  Baxter BAX | $15.81 B | $30.82 | 0.65% | USA | |
| 52 |  Alteogen 196170.KQ | $15.53 B | $291.56 | 1.97% | S. Korea | |
| 153 |  Summit Therapeutics SMMT | $14.81 B | $19.95 | 0.86% | UK | |
| 154 |  Shionogi 4507.T | $14.67 B | $17.25 | 0.48% | Japan | |
| 355 |  Illumina ILMN | $14.28 B | $90.25 | 3.82% | USA | |
| 156 |  Cipla CIPLA.NS | $14.10 B | $17.47 | 1.51% | India | |
| 157 |  Genmab GMAB | $14.07 B | $22.86 | 0.18% | Denmark | |
| 358 |  Incyte INCY | $13.78 B | $71.22 | 5.12% | USA | |
| 459 |  WuXi Biologics WXXWY | $13.72 B | $6.69 | 3.04% | China | |
| 160 |  Dr. Reddy’s Laboratories RDY | $13.08 B | $15.72 | 0.51% | India | |
| 161 |  Recordati REC.MI | $13.03 B | $62.64 | 0.91% |  Italy | |
| 62 |  United Therapeutics UTHR | $13.01 B | $288.56 | 1.84% | USA | |
| 63 |  Torrent Pharmaceuticals TORNTPHARM.NS | $12.80 B | $37.82 | 0.60% | India | |
| 64 |  Tempus AI TEM | $12.46 B | $72.00 | 0.95% | USA | |
| 65 |  Neurocrine Biosciences NBIX | $12.37 B | $125.00 | 0.49% | USA | |
| 66 |  ICON plc ICLR | $11.68 B | $147.04 | 0.95% |  Ireland | |
| 367 |  Exelixis EXEL | $11.38 B | $41.75 | 0.38% | USA | |
| 468 |  Revvity RVTY | $11.35 B | $96.35 | 3.02% | USA | |
| 169 |  Zydus Lifesciences ZYDUSLIFE.NS | $11.19 B | $11.12 | 1.73% | India | |
| 370 |  CSPC Innovation Pharmaceutical 300765.SZ | $10.95 B | $7.80 | 3.25% | China | |
| 71 |  Mankind Pharma MANKIND.NS | $10.93 B | $27.30 | 0.83% | India | |
| 272 |  BioMarin Pharmaceutical BMRN | $10.78 B | $56.24 | 0.04% | USA | |
| 473 |  Akeso 9926.HK | $10.75 B | $11.98 | 4.86% | China | |
| 374 |  Ascendis Pharma ASND | $10.75 B | $177.71 | 4.05% | Denmark | |
| 175 |  Viatris VTRS | $10.55 B | $8.99 | 0.78% | USA | |
| 176 |  Lupin Limited LUPIN.NS | $10.28 B | $22.52 | 3.58% | India | |
| 477 |  Qiagen QGEN | $10.27 B | $47.45 | 0.72% | Netherlands | |
| 278 |  Orion Corporation ORNAV.HE | $10.25 B | $72.70 | 0.16% |  Finland | |
| 679 |  Huadong Medicine (HD Medicine) 000963.SZ | $10.23 B | $5.84 | 4.08% | China | |
| 280 |  Swedish Orphan Biovitrum SOBI.ST | $10.14 B | $29.55 | 2.84% |  Sweden | |
| 281 |  Moderna MRNA | $10.05 B | $26.00 | 2.51% | USA | |
| 82 |  Exact Sciences EXAS | $10.05 B | $53.30 | 0.41% | USA | |
| 83 |  Ipsen IPN.PA | $9.91 B | $119.51 | 0.39% | France | |
| 84 |  kyowa Kirin 4151.T | $8.96 B | $17.13 | 0.64% | Japan | |
| 85 |  Medpace MEDP | $8.65 B | $300.98 | 0.92% | USA | |
| 186 |  Blueprint Medicines BPMC | $8.29 B | $128.25 | 0.23% | USA | |
| 187 |  Bio-Techne TECH | $8.09 B | $51.63 | 2.20% | USA | |
| 288 |  Verona Pharma VRNA | $7.87 B | $92.70 | 0.54% | UK | |
| 289 |  Abbott India ABBOTINDIA.NS | $7.84 B | $369.37 | 0.39% | India | |
| 690 |  BridgeBio Pharma BBIO | $7.81 B | $41.14 | 3.42% | USA | |
| 291 |  Eisai 4523.T | $7.80 B | $27.67 | 0.60% | Japan | |
| 292 |  Roivant Sciences ROIV | $7.53 B | $11.08 | 2.12% | UK | |
| 793 |  Shenzhen Salubris Pharmaceuticals 002294.SZ | $7.52 B | $6.75 | 9.95% | China | |
| 394 |  Corcept Therapeutics CORT | $7.51 B | $70.90 | 1.20% | USA | |
| 595 |  Grifols GRFS | $7.51 B | $9.09 | 2.48% |  Spain | |
| 496 |  Aurobindo Pharma AUROPHARMA.NS | $7.48 B | $12.89 | 3.09% | India | |
| 297 |  Charles River Laboratories CRL | $7.41 B | $151.03 | 1.06% | USA | |
| 398 |  Revolution Medicines RVMD | $7.40 B | $39.77 | 2.02% | USA | |
| 199 |  Sinopharm 1099.HK | $7.31 B | $2.34 | 0.22% | China | |
| 1100 |  Repligen RGEN | $7.08 B | $126.09 | 1.12% | USA | |
Continue at: https://companiesmarketcap.com/biotech/largest-companies-by-market-cap/?page=1
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:
Manostaxx – Industrial Management Consulting
